Alemtuzumab

Humanized monoclonal antibody specific to lymphocyte antigens. It is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) that is directed against the 21-28 kD cell surface glycoprotein,CD52. The Campath-1H antibody is an IgG1 kappa with human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody (Campath-1G). Campath is produced in mammalian cell (Chinese hamster ovary) suspension culture in a medium containing neomycin.

Price Not Available 1 mg Alemtuzumab Supplier Page
Trivial name Alemtuzumab
Catalog Number TP-081CL
Alternative Name(s) Alemtuzumab
Research Area Cancer
Molecular Formula C6468H10066N1732O2005S40
CAS# 216503-57-0
Purity >90%
Size 1 mg
Supplier Page https://www.creativebiolabs.net/Alemtuzumab-22419.htm
Additional Information Alemtuzumab (Campath) is a monoclonal antibody therapy used for treatment of B-cell chronic lymphocytic leukemia.